65 related articles for article (PubMed ID: 25824771)
1. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
[TBL] [Abstract][Full Text] [Related]
2. SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA-17.
Pan S; Bao D; Li Y; Liu D; Quan S; Wang R
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22910. PubMed ID: 34927777
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
Zhao Y; Miao G; Li Y; Isaji T; Gu J; Li J; Qi R
PLoS One; 2014; 9(2):e87938. PubMed ID: 24498407
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.
Lv H; Zhang Z; Wang Y; Li C; Gong W; Wang X
Oncol Res; 2016; 23(6):283-90. PubMed ID: 27131314
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.
Yuan K; Xie K; Fox J; Zeng H; Gao H; Huang C; Wu M
Gastroenterology; 2013 Oct; 145(4):853-64.e9. PubMed ID: 23770133
[TBL] [Abstract][Full Text] [Related]
6. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling.
Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J
Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells.
Kim JS; Yu SK; Lee MH; Park MG; Park E; Kim SG; Lee SY; Kim CS; Kim HJ; Chun HS; Chun SW; Kim DK
Mol Cells; 2013 Jan; 35(1):17-24. PubMed ID: 23212344
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy.
Wei L; Chen Z; Cheng N; Li X; Chen J; Wu D; Dong M; Wu X
Onco Targets Ther; 2020; 13():2459-2468. PubMed ID: 32273718
[TBL] [Abstract][Full Text] [Related]
9. IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer.
Andres SF; Williams KN; Plesset JB; Headd JJ; Mizuno R; Chatterji P; Lento AA; Klein-Szanto AJ; Mick R; Hamilton KE; Rustgi AK
Carcinogenesis; 2019 Jun; 40(4):569-579. PubMed ID: 30407516
[TBL] [Abstract][Full Text] [Related]
10. The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.
Rajan N; Elliott RJ; Smith A; Sinclair N; Swift S; Lord CJ; Ashworth A
Oncotarget; 2014 Dec; 5(23):12126-40. PubMed ID: 25565632
[TBL] [Abstract][Full Text] [Related]
11. CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression.
Gu Y; Wu S; Fan J; Meng Z; Gao G; Liu T; Wang Q; Xia H; Wang X; Wu K
Cell Death Dis; 2024 Jan; 15(1):79. PubMed ID: 38246916
[TBL] [Abstract][Full Text] [Related]
12. A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.
Huang Y; Zhang W; Yu Z; Su H; Zeng B; Piao J; Wang J; Wu J
Clin Med Insights Oncol; 2023; 17():11795549231180832. PubMed ID: 37359274
[TBL] [Abstract][Full Text] [Related]
13. miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.
Niu G; Li B; Sun J; Sun L
Cell Prolif; 2015 Jun; 48(3):348-55. PubMed ID: 25880599
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.
Tesio M; Tang Y; Müdder K; Saini M; von Paleske L; Macintyre E; Pasparakis M; Waisman A; Trumpp A
J Exp Med; 2015 Apr; 212(4):525-38. PubMed ID: 25824820
[TBL] [Abstract][Full Text] [Related]
15. MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.
Huang DH; Wang GY; Zhang JW; Li Y; Zeng XC; Jiang N
Jpn J Clin Oncol; 2015 Aug; 45(8):738-44. PubMed ID: 25917358
[TBL] [Abstract][Full Text] [Related]
16. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
Ge YZ; Xu LW; Xu Z; Wu R; Xin H; Zhu M; Lu TZ; Geng LG; Liu H; Zhou CC; Yu P; Zhao YC; Hu ZK; Zhao Y; Zhou LH; Wu JP; Li WC; Zhu JG; Jia RP
Medicine (Baltimore); 2015 Apr; 94(16):e767. PubMed ID: 25906110
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of NAMPT related with susceptibility to esophageal squamous cell carcinoma.
Zhang C; Yan D; Wang S; Xu C; Du W; Ning T; Liu C; Zhang M; Hou R; Chen Z
BMC Gastroenterol; 2015 Apr; 15():49. PubMed ID: 25896907
[TBL] [Abstract][Full Text] [Related]
18. Paired design study by real-time PCR: miR-378* and miR-145 are potent early diagnostic biomarkers of human colorectal cancer.
Peng J; Xie Z; Cheng L; Zhang Y; Chen J; Yu H; Li Z; Kang H
BMC Cancer; 2015 Mar; 15():158. PubMed ID: 25896668
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.
Shahbaz M; Ruliang F; Xu Z; Benjia L; Cong W; Zhaobin H; Jun N
World J Surg Oncol; 2015 Feb; 13():46. PubMed ID: 25890201
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas.
Chen J; Liu Z; Fang S; Fang R; Liu X; Zhao Y; Li X; Huang L; Zhang J
BMC Cancer; 2015 Mar; 15():91. PubMed ID: 25885889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
